Regression of CD8+ pseudolymphoma after HIV antiviral triple therapy

J Am Acad Dermatol. 2003 Jul;49(1):139-41. doi: 10.1067/mjd.2003.299.

Abstract

To our knowledge, we report the first case of improvement of HIV-associated cutaneous CD8(+) pseudolymphoma with highly active antiretroviral therapy. This favors the hypothesis of a reactive cutaneous infiltration by HIV-specific cytotoxic T cells in this disease.

Publication types

  • Case Reports

MeSH terms

  • Antiretroviral Therapy, Highly Active*
  • CD8-Positive T-Lymphocytes / metabolism*
  • Fatal Outcome
  • Humans
  • Lymphoma, AIDS-Related / complications
  • Lymphoma, AIDS-Related / drug therapy*
  • Lymphoma, T-Cell, Cutaneous / complications
  • Lymphoma, T-Cell, Cutaneous / drug therapy*
  • Male
  • Middle Aged
  • Pseudolymphoma / complications
  • Pseudolymphoma / drug therapy*
  • Remission Induction
  • Skin Neoplasms / complications
  • Skin Neoplasms / drug therapy*
  • Status Epilepticus / complications